BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0559 reviews
Vote for Target Test Prep, Newsweek Readers’ Choice Awards 2026
NEWSWEEK READERS’ CHOICE 2026

BIG NEWS! Target Test Prep has been nominated, and they’d love your vote!

TTP has worked incredibly hard to build the best test prep experience possible, and winning Newsweek’s 2026 Readers’ Choice Award for Best Test Prep would mean a lot to them. If TTP has helped you, they’d be incredibly grateful for your vote. You can vote once each day through September 9.

Vote for TTP
GMATLiveTeach 7 seats left
Chris Peckover
NEXT LIVE COHORT

Oct 13 to Jan 7, 2027

with Chris Peckover

Schedule
Tue, Thu · 8:00 to 10:00 PM ET
Included
40 live hours + 6 months of GMAT OnDemand
  • Live instruction and real-time questions
  • Class recordings and assigned practice
View class & enroll
Limited cohort · enrollment openTarget Test Prep
EALiveTeach 5 seats left
Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll
Limited cohort · enrollment openTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

The FDA CR

Expert replies
by aj5105 » Mon May 11, 2009 2:07 am
The United States Food and Drug Administration (FDA) regulates the introduction of new therapeutic agents into the marketplace. Consequently, it plays a critical role in improving health care in the United States. While it is those in the academic and government research communities who engage in the long process of initial discovery and clinical testing of new therapeutic agents, it is the FDA’s role and responsibility to facilitate the transfer of new discoveries from the laboratory to the marketplace. Only after the transfer can important new therapies help patients.
Which one of the following statements can be inferred from the passage?

(A) The FDA is responsible for ensuring that any therapeutic agent that is marketed is then regulated.

(B) Before new therapeutic agents reach the marketplace they do not help patients.

(C) The research community is responsible for the excessively long testing period for new drugs, not the FDA.

(D) The FDA should work more closely with researchers to ensure that the quality of therapeutic agents is maintained.

(E) If a new medical discovery has been transferred from the laboratory to the marketplace, it will help patients.
Join the discussion
Source: — Critical Reasoning |

Re: The FDA CR

by Pranay » Mon May 11, 2009 2:59 am
aj5105 wrote:The United States Food and Drug Administration (FDA) regulates the introduction of new therapeutic agents into the marketplace. Consequently, it plays a critical role in improving health care in the United States. While it is those in the academic and government research communities who engage in the long process of initial discovery and clinical testing of new therapeutic agents, it is the FDA’s role and responsibility to facilitate the transfer of new discoveries from the laboratory to the marketplace. Only after the transfer can important new therapies help patients.
Which one of the following statements can be inferred from the passage?

(A) The FDA is responsible for ensuring that any therapeutic agent that is marketed is then regulated.

(B) Before new therapeutic agents reach the marketplace they do not help patients.

(C) The research community is responsible for the excessively long testing period for new drugs, not the FDA.

(D) The FDA should work more closely with researchers to ensure that the quality of therapeutic agents is maintained.

(E) If a new medical discovery has been transferred from the laboratory to the marketplace, it will help patients.
I go with D.

Please post the correct answer and will post my way of deducing the answer, if correct.
Join the discussion

by ketkoag » Mon May 11, 2009 3:51 am
IMO B
Join the discussion

by preetosh » Mon May 11, 2009 8:26 am
I was confused a bit between B and E , but will go with B

OA please?
Join the discussion

by krisraam » Mon May 11, 2009 8:47 am
IMO E.

Thanks
Raama
Join the discussion

by schumi_gmat » Mon May 11, 2009 9:13 am
IMO B

(A) The FDA is responsible for ensuring that any therapeutic agent that is marketed is then regulated.
Introduction of therapies are regulated........first sentence


(B) Before new therapeutic agents reach the marketplace they do not help patients.
correct........Last stmt


(C) The research community is responsible for the excessively long testing period for new drugs, not the FDA.

Extreme word, excessively

(D) The FDA should work more closely with researchers to ensure that the quality of therapeutic agents is maintained.
IRrelevant

(E) If a new medical discovery has been transferred from the laboratory to the marketplace, it will help patients. There is a possibility not certainty in the argument
Join the discussion

by mehravikas » Mon May 11, 2009 1:00 pm
IMO - B

Argument - Only after the transfer can important new therapies help patients.

Therefore, B can be inferred from the argument.
Join the discussion

by rahulg83 » Tue May 12, 2009 9:42 pm
IMO B...

E says
If a new medical discovery has been transferred from the laboratory to the marketplace, it will help patients.
I guess "medical discoveries" are different from "therapeutic agents". Medical discoveries is a too general term to attribute it to helping of patients.
Please post the OA
Join the discussion

Re: The FDA CR

by thetrystero » Wed May 13, 2009 1:05 am
aj5105 wrote:The United States Food and Drug Administration (FDA) regulates the introduction of new therapeutic agents into the marketplace. Consequently, it plays a critical role in improving health care in the United States. While it is those in the academic and government research communities who engage in the long process of initial discovery and clinical testing of new therapeutic agents, it is the FDA’s role and responsibility to facilitate the transfer of new discoveries from the laboratory to the marketplace. Only after the transfer can important new therapies help patients.
Which one of the following statements can be inferred from the passage?

(A) The FDA is responsible for ensuring that any therapeutic agent that is marketed is then regulated.

(B) Before new therapeutic agents reach the marketplace they do not help patients.

(C) The research community is responsible for the excessively long testing period for new drugs, not the FDA.

(D) The FDA should work more closely with researchers to ensure that the quality of therapeutic agents is maintained.

(E) If a new medical discovery has been transferred from the laboratory to the marketplace, it will help patients.

My answer: C
1. Researchers discover drugs and perform testing
2. FDA transfers drug from lab to market
3. After transfer, drug can help patients.

A,B,D are nowhere stated in the problem.
E: problem says that drugs "can" help the patient, but it is not a 100% guarantee that they will.
C: same as what is said in the problem statement.
Join the discussion

by thetrystero » Wed May 13, 2009 1:12 am
I'm swayed. looks like B it is.
Join the discussion

by anshulseth » Wed May 13, 2009 9:05 pm
The whole Q stem talks abt FDA. Where is it lost in B? That rules it out.

IMO D. As argument says that though researches do the testing for the agents, but its FDA who finally passes it to marketplace. If they work closely with researchers, the quality of the agents can be maintained.
Asset
Join the discussion

by thetrystero » Wed May 13, 2009 9:46 pm
@aj5105 OA please.
Join the discussion

by 2010gmat » Thu May 14, 2009 1:34 am
B :D

Only after the transfer can important new therapies help patients.

THATS WAT b SAYS
Join the discussion

Re: The FDA CR

by success1111 » Thu May 14, 2009 9:22 am
aj5105 wrote:The United States Food and Drug Administration (FDA) regulates the introduction of new therapeutic agents into the marketplace. Consequently, it plays a critical role in improving health care in the United States. While it is those in the academic and government research communities who engage in the long process of initial discovery and clinical testing of new therapeutic agents, it is the FDA’s role and responsibility to facilitate the transfer of new discoveries from the laboratory to the marketplace. Only after the transfer can important new therapies help patients.
Which one of the following statements can be inferred from the passage?

(A) The FDA is responsible for ensuring that any therapeutic agent that is marketed is then regulated.

(B) Before new therapeutic agents reach the marketplace they do not help patients.

(C) The research community is responsible for the excessively long testing period for new drugs, not the FDA.

(D) The FDA should work more closely with researchers to ensure that the quality of therapeutic agents is maintained.

(E) If a new medical discovery has been transferred from the laboratory to the marketplace, it will help patients.
Apply contrapositive.
"Only after the transfer can important new therapies help patients."

The contrapositive of this sentence is "before transfer,new therapies do not help",which is essentially what B says. Choose B with confidence.
Trust but verify.
Join the discussion

by wondering » Thu May 14, 2009 9:35 am
IMO B
Join the discussion